Effect of weekly or successive iron supplementation on erythropoietin doses in patients receiving hemodialysis

Nephron

Volumn 89, Issue 1, 2001, Pages 110-112

  Kato, Akihiko ^a   Hamada, Mayumi ^b   Suzuki, Takayuki ^b   Maruyama, Takanori ^b   Maruyama, Yukitaka ^b   Hishida, Akira ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Maruyama Hospital   (Japan)

Author keywords

Erythropoietin; Hemodialysis; Iron; Resistance; rHuEPO

Indexed keywords

FERRITIN; HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; CLINICAL ARTICLE; FEMALE; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; IRON BINDING CAPACITY; IRON DEFICIENCY; IRON STORAGE; IRON THERAPY; MALE; PRIORITY JOURNAL;

AGED; ANEMIA, IRON-DEFICIENCY; DRUG THERAPY, COMBINATION; ERYTHROPOIETIN; FEMALE; HEMOGLOBINS; HUMANS; IRON; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 0034875434     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000046053     Document Type: Article

References (4)

1. NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure
2. A study of parental iron regimens in hemodialysis patients
3. A randomized trial of three iron dextran infusion methods for anemia of erythropoietin treated dialysis patients
4. Comparative response to single or divided doses of parental iron for functional iron deficiency in hemodialysis patients receiving erythropoietin (EPO)